CEBPA and liposarcoma: H3K9me3 inhibition reduced tumor proliferation and increased expression of the adipogenesis regulation factors CEBP (CCAAT/enhancer binding protein) α, CEBPβ, and PPARγ, indicating that enhanced H3K9me3 mediates dedifferentiated liposarcoma-associated dedifferentiation.